Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma M Cousin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 3, 2025
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Predict Initial Price Offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027)Kevin H Li, Emma M Cousin, Nico Gabriel, et al.
Journal of Managed Care & Specialty Pharmacy|November 14, 2025
Drugs anticipated to be selected for Medicare price negotiation in 2026 for implementation in 2028Emma M Cousin, Kristi Martin, Ryan N Hansen, et al.
Journal of Managed Care & Specialty Pharmacy|September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiationSean D Sullivan, Emma M Cousin, Kevin H Li, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 18, 2024
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation ProgramSean D Sullivan, Olivier J Wouters, Emma M Cousin, et al.
Journal of Managed Care & Specialty Pharmacy|June 21, 2024
Price benchmarks of drugs selected for Medicare price negotiation and their therapeutic alternativesInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|December 13, 2023
Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectivenessInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.
Journal of Managed Care & Specialty Pharmacy|September 19, 2024
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025Emma M Cousin, Sean D Sullivan, Ryan N Hansen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 3, 2025
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Predict Initial Price Offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027)Kevin H Li, Emma M Cousin, Nico Gabriel, et al.
Journal of Managed Care & Specialty Pharmacy|November 14, 2025
Drugs anticipated to be selected for Medicare price negotiation in 2026 for implementation in 2028Emma M Cousin, Kristi Martin, Ryan N Hansen, et al.
Journal of Managed Care & Specialty Pharmacy|September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiationSean D Sullivan, Emma M Cousin, Kevin H Li, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 18, 2024
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation ProgramSean D Sullivan, Olivier J Wouters, Emma M Cousin, et al.
Journal of Managed Care & Specialty Pharmacy|June 21, 2024
Price benchmarks of drugs selected for Medicare price negotiation and their therapeutic alternativesInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|December 13, 2023
Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectivenessInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.
Journal of Managed Care & Specialty Pharmacy|September 19, 2024
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025Emma M Cousin, Sean D Sullivan, Ryan N Hansen, et al.
Pageof 1